Background and Purpose-Cross-sectional studies suggest that chronic hemodynamic impairment may cause selective cortical neuronal damage in patients with atherosclerotic internal carotid artery or middle cerebral artery occlusive disease. The purpose of this longitudinal study was to determine whether the progression of cortical neuronal damage, evaluated as a decrease in central benzodiazepine receptors (BZRs), is associated with hemodynamic impairment at baseline or hemodynamic deterioration during follow-up. Methods-We evaluated the distribution of BZRs twice using positron emission tomography and 11 C-flumazenil over time in 80 medically treated patients with atherosclerotic internal carotid artery or middle cerebral artery occlusive disease that had no ischemic episodes during follow-up. Using 3D stereotactic surface projections, we quantified abnormal decreases in the BZRs in the cerebral cortex within the middle cerebral artery distribution and correlated changes in the BZR index with the mean hemispheric values of hemodynamic parameters obtained from 15 O gas positron emission tomography. Results-In the hemisphere affected by arterial disease, the BZR index in 40 patients (50%) was increased during follow-up (mean 26±20 months). In multivariable logistic regression analyses, increases in the BZR index were associated with the decreased cerebral blood flow at baseline and an increased oxygen extraction fraction during follow-up. Increases in the oxygen extraction fraction during follow-up were associated with a lack of statin use. Conclusions-In patients with atherosclerotic internal carotid artery or middle cerebral artery disease, the progression of cortical neuronal damage was associated with hemodynamic impairment at baseline and hemodynamic deterioration during follow-up. Statin use may be beneficial against hemodynamic deterioration and therefore neuroprotective. 
I
n patients with atherosclerotic internal carotid artery (ICA) or middle cerebral artery (MCA) occlusive disease, the chronic reduction in cerebral perfusion pressure increases the risk of cerebral ischemic damage. [1] [2] [3] Previous studies have shown that hemodynamic impairment at baseline or hemodynamic deterioration during follow-up is a predictor of subsequent ischemic stroke. 2, 4, 5 Therefore, early detection and careful management of chronic hemodynamic impairment are essential to improve patient prognosis.
In patients with chronic hemodynamic impairment, transient decreases in perfusion pressure can reduce perfusion below the penumbra threshold for a period of minutes, which may cause selective neuronal damage. [6] [7] [8] Experimental models have demonstrated the development of selective neuronal necrosis after arterial occlusion with resultant ischemia of moderate severity. [9] [10] [11] However, the pathophysiology of neuronal damage after chronic hemodynamic impairment in humans has not been well studied because of difficulties with in vivo imaging. Because most cortical neurons express central-type benzodiazepine receptors (BZRs), specific imaging of these receptors has made possible the in vivo visualization of neuronal alterations induced by ischemia. 10, 12, 13 Selective neuronal damage can be detected in humans using positron emission tomography (PET) and 11 C-flumazenil (FMZ), a neuronal tracer. This mode of imaging has been validated against immunohistochemistry in rodent models of stroke.
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Previous cross-sectional studies have demonstrated selective cortical neuronal damage manifesting as a decrease in BZRs in the normal-appearing cerebral cortex of patients, and this damage has been associated with increased oxygen extraction fraction (OEF) (ie, misery perfusion 1 ) in patients However, in these studies, it was unclear whether hemodynamic impairment was directly associated with selective cortical neuronal damage. In a preliminary work performed by our group, we observed that decreases in BZRs were correlated with increases in OEF during follow-up in 17 patients with atherosclerotic ICA or MCA disease. 7 Indeed, hemodynamic deterioration during follow-up may be a risk factor for the progression of cortical neuronal damage. The elucidation of these relationships is clinically important: vascular reconstruction surgery is an option that can improve chronic hemodynamic impairment, 1 and thus research is needed to determine whether surgical intervention should be used to prevent the development of selective neuronal damage in patients with hemodynamic impairment. Additionally, given its association with cognitive impairment, selective neuronal damage may constitute a novel and important target for the treatment of patients with chronic hemodynamic impairment. 14, 15 The purpose of this longitudinal study was to determine whether selective cortical neuronal damage manifests as a decrease in BZRs in the normal-appearing cerebral cortex of patients with atherosclerotic ICA or MCA occlusive disease and furthermore whether these changes can be correlated with chronic hemodynamic impairment at baseline or hemodynamic deterioration.
Methods

Patients
We studied 80 patients, aged 63±8 (mean±SD) years, including 52 men and 28 women, with atherosclerotic occlusion or stenosis of the ICA or MCA using PET (Table 1) . Seventeen patients were part of a previously published data set. 7 Patients were referred to our PET unit for evaluation of the hemodynamic effects of ICA or MCA disease as part of a comprehensive clinical evaluation to determine the necessity of vascular reconstruction surgery.
Inclusion criteria were as follows: (1) 17 ) as documented by conventional or magnetic resonance angiography, (2) functional independence in daily life (a modified Rankin Scale score <3), (3) for symptomatic patients, history of transient ischemic attack or minor completed stroke in ICA or MCA distribution, (4) medically treated patients with no intervening transient ischemic attack or stroke since the first PET examination, and (5) availability and willingness to return for follow-up PET examination. Transient ischemic attack was defined as focal symptoms of presumed ischemic cerebrovascular origin lasting <24 hours. Exclusion criteria were (1) cerebral-cortical, cerebellar, or brain stem infarct detectable on routine magnetic resonance imaging (MRI) (T 1 -weighted, T 2 -weighted, or fluid-attenuated inversion recovery imaging) or computed tomography imaging, (2) history of vascular reconstruction surgery, (3) unilateral arterial disease with extensive white matter lesions in both hemispheres probably caused by bilateral small vessel disease, (4) history of taking BZR agonists, and (5) presence of potential sources of cardiogenic embolism.
Of 80 patients, 25 were asymptomatic, 17 had transient ischemic attack, and 38 had completed stroke. In the same patient cohort, 33 had ICA occlusion, 10 had ICA stenosis, 28 had MCA occlusion, and 9 had MCA stenosis. The interval between the first and follow-up PET studies ranged from 3 to 108 months (mean: 26±20 months). During follow-up, 59 patients were treated with antiplatelet therapy (aspirin, ticlopidine HCl, or clopidogrel) and 27 patients were treated with statin. For 22 patients, statin treatment was combined with antiplatelet agents.
For vascular risk factors, status with respect to hypertension, diabetes mellitus, ischemic heart disease, hypercholesterolemia, and smoking was evaluated from patient history recorded at the first PET examination. Hypertension, diabetes mellitus, ischemic heart disease, or hypercholesterolemia was judged to be present when there was a history of treatment.
To establish a control database for BZR imaging, we studied 10 healthy control subjects, aged 57±7 years, including 7 men and 3 women with no history of medical or psychiatric disorder or of taking BZR agonists. Among them, 7 subjects, aged 56±8 years, including 4 men and 3 women, attended follow-up PET examinations. The interval between the first and follow-up PET studies ranged from 38 to 45 months (mean: 41±3 months). All protocols in this study were approved by the ethics committee of our center, and all subjects gave in written informed consent.
PET Measurements
PET scans were performed in each subject using an Advance wholebody scanner (General Electric Medical Systems, Wauwatosa, WI), which permits the simultaneous acquisition of 35 image slices with an interslice spacing of 4.25 mm. 18 After a transmission scan using O-gas study was followed by a study of 11 C-FMZ, 6, 7, 19 which was synthesized by 11 C-methylation of demethylated-FMZ (Hoffmann-La Roche, Basel, Switzerland). After the slow intravenous injection of 11 C-FMZ, a 50-minute dynamic PET scan was initiated.
We used the steady-state method to calculate cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO 2 ), and OEF. 20 The CMRO 2 and OEF were corrected on the basis of CBV. The binding potential (BP [nondisplaceable]) of 11 C-FMZ was calculated using dynamic data and Logan graphical analysis with reference tissue, with the pons as the reference region.
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Data Analysis
The 15 O gas PET-scanning analysis used a classical region-of-interest (ROI) analysis. We analyzed 10 tomographic planes, located 46.25 to 84.5 mm above and parallel to the orbitomeatal line. 22 The lowest plane corresponded to the level of the basal ganglia and the thalamus, and the uppermost plane corresponded to the level of the centrum semiovale. A ROI was selected for CBF images. Each image was examined by compactly placing 10 to 12 circular ROIs (diameter: 16 mm) over the gray matter of the outer cortex in each hemisphere. According to the atlas, 23 the ROIs in all 10 images covered the distribution of the MCA as well as the external border zone regions. 22, 23 The same ROIs were used for the CMRO 2 , OEF, and CBV images. The mean hemispheric value for the hemisphere affected by ICA or MCA disease was calculated as the average of all the circular ROIs.
FMZ BP parametric images were analyzed using a 3D stereotactic surface projection technique, as previously described. 7, 24 This technique anatomically normalized individual PET data to the standard brain and compared regional voxel data between patients and controls. In the standard stereotactic system, pixels located on the outer and medial surfaces of both hemispheres and vectors perpendicular to the 3D surface at each pixel were predetermined. For each predetermined surface pixel on an individual's anatomically standardized PET image set, the algorithm searched along the vector, 6 pixels deep into the cortex, for the highest pixel value, and assigned this maximum value to the surface pixel. To correct for fluctuations in whole-brain values and to extract the changes because of ICA or MCA disease, the pixel values of an individual's image set were normalized to the mean cerebellar value before analysis. Z scores were calculated for each surface pixel (calculated as [mean normalized pixel value for controls − normalized pixel value for the patient]/SD for controls) and used to quantify decreases in FMZ BP. Thus, a positive Z score in a patient represented reduced FMZ BP relative to the control group.
To quantify the degree of abnormal FMZ BP reduction in each patient, the stereotactic extraction estimation method was used to calculate a BZR index (defined as [% pixels with Z score >2] × [average Z score for those pixels]) for the cerebral-cortical MCA distribution affected by ICA or MCA disease. 25 This MCA distribution included the middle and inferior frontal gyri; the precentral gyrus; the superior and inferior parietal gyri; the angular, postcentral, and supramarginal gyri; the superior, middle, inferior, and transverse temporal gyri; and the superior and middle occipital gyri. 25 At follow-up examinations, total change in the BZR index or the CBF, CMRO 2 , OEF, CBV, or CBF/CBV values in the MCA distribution with arterial disease was calculated by subtracting the values obtained at the follow-up examination from those obtained at the first examination. In controls, the calculation was performed using the mean of the bilateral hemispheric values of the BZR index. The mean±SD value of changes in the index in the controls was 0.94±1.38. In patients, increase of the by guest on October 15, 2017 http://stroke.ahajournals.org/ Downloaded from index beyond the upper 95% limit (the mean plus 6 t 0.05 SD) defined in normal subjects (above 4.32) was considered to be an increased BZR index (progression of neuronal damage) during follow-up.
Statistical Analysis
Clinical backgrounds were compared between groups using the Student t test, Mann-Whitney U test, or Fisher exact test, as appropriate. The relationships between variables were analyzed using simple or multiple regression analyses or the Spearman rank correlation analysis, as appropriate. A multivariable logistic regression model with a forward stepwise selection procedure was used to test the independent predictive value of PET hemodynamic variables at baseline and the change in variables during follow-up with respect to the increased BZR index. For all analyses, statistical significance was accepted at P<0.05.
Results
Forty patients (50%) showed an increase in BZR index beyond the upper 95% limit defined in normal subjects (Figures 1 and  2 ). No patient characteristics significantly differed between the 2 groups, except for BZR index (Table 1) .
In the hemisphere affected by arterial disease, T 2 -weighted MRI at the follow-up evaluation disclosed extension of the preexisting confluent white matter lesions in 1 stroke patient and an increase in punctate high-intensity lesions in the subcortical white matter of 1 asymptomatic patient and in the thalamus of 1 stroke patient. In the hemisphere contralateral to arterial disease, an increase in punctate high-intensity lesions in the basal ganglia was identified in 2 stroke patients. The other 75 patients did not show apparent MRI changes at follow-up. The incidence of these changes did not significantly differ between patients with or without an increased BZR index at follow-up (3/40 versus 2/40; Fisher exact test, P>0.99).
Follow-up findings on MR angiography included an increase in the degree of stenosis in 1 patient with MCA stenosis and in 3 patients with ICA stenosis and apparent stenosis in 2 patients (severe stenosis of the branch of the ipsilateral MCA and mild stenosis of the contralateral PCA). The incidence of these MR angiography changes significantly differed between patients with and without an increased BZR index at follow-up (6/40 versus 0/40; Fisher exact test, P=0.025).
Patients with an increased BZR index in follow-up imaging had a lower CBF value at baseline, lower CBF, CMRO 2 , and CBF/CBV values at follow-up, and a tendency towards higher OEF values that approached statistical significance at follow-up (P=0.06), and a larger change in the OEF at followup (P=0.13; Table 2 ). Changes in the OEF at follow-up were negatively correlated with OEF values at baseline in patients (Spearman, ρ=−0.59; P<0.01).
In a multivariable logistic regression analysis (forward stepwise selection) of the values of CBF, CMRO 2 , OEF, CBV, or CBF/CBV at baseline and changes in those values during follow-up, CBF at baseline and change (increase) in the OEF during follow-up emerged as significant independent predictors for increases in the BZR index (Table 3 , model 1). The CBF value at baseline and change in the OEF during follow-up were also significant independent predictors of the increase of the BZR index, after inclusion of the interval between the first and follow-up PET examinations in the model (model 2). Changes in the BZR index during follow-up were negatively correlated with CBF values at baseline and positively correlated with changes in the OEF during follow-up ( Figure 2) .
A multiple linear regression analysis (forward stepwise selection) was used to investigate the contribution of primary ischemia (misery perfusion) and secondary reduction of CBF because of decreased metabolism (selective neuronal damage or deafferentation caused by subcortical ischemic lesions) to CBF value at baseline. Our analysis produced a model that included the OEF value and the BZR index at baseline with a correlation coefficient of 0.687 for the CBF value at baseline (P<0.01), in which the OEF and BZR index accounted for 31.5% and 14.3% of the variance in CBF, respectively. The presence of subcortical ischemic lesions did not significantly contribute to the magnitude of the correlation. Furthermore, the OEF value (%) (coefficient, −0.50; SE, 0.094; t=−5.37; P<0.01) and the BZR index (coefficient, −0.095; SE, 0.021; t=−4.65; P<0.01) were negatively correlated with the CBF value.
We also investigated the association of changes in the OEF during follow-up with the presence of vascular risk factors and drug treatment history (shown in Table 1 ). A multiple linear regression analysis (forward stepwise selection) produced a model that included statin use during follow-up Twenty-five asymptomatic patients were included in this study. Twelve asymptomatic patients had an increased BZR index during follow-up, whereas 13 did not (12/40 versus 13/40; Fisher exact test, P>0.99). Asymptomatic patients had a lower BZR index and higher CBF, CMRO 2 , and CBF/CBV at baseline than symptomatic patients (Table 4) . At follow-up, no measures differed between these 2 groups. Changes in the BZR index did not significantly differ between the symptomatic and asymptomatic patients. Changes in CMRO 2 , CBV, and CBF/CBV values were significantly different between these 2 patient groups.
Discussion
This longitudinal study demonstrates an association between chronic hemodynamic impairment and the progression of selective cortical neuronal damage in patients with atherosclerotic ICA or MCA disease and no ischemic episodes of stroke during follow-up. Selective cortical neuronal damage during follow-up was indicated by an increase in the BZR index of the normal-appearing cerebral cortex and was predicted by decreased CBF at baseline and a change (increase) in the OEF during follow-up. Additionally, increases in the OEF during follow-up were most commonly detected in patients who did not use statins.
Hemodynamic impairment at baseline may be a predictor for progressive selective cortical neuronal damage and subsequent ischemic stroke in patients with atherosclerotic ICA or MCA disease. In this study, we found that decreased CBF associated with the progression of cortical neuronal damage was explained by an increased OEF and increased BZR index at baseline, suggesting that the decreased CBF may have been a reflection of both misery perfusion and decreased cortical metabolism. Patients with an increased OEF (misery perfusion) have a marginally adequate blood supply relative to metabolic demand, which increases the risk of cerebral ischemia. 1, 3, 5 Therefore, it is reasonable to hypothesize that misery perfusion at baseline is associated with subsequent development of ischemic cortical neuronal damage. The contribution of the increased BZR index at baseline suggests that patients with misery perfusion have already suffered some ischemic cortical neuronal damage and may be at particular risk for progressive cortical neuronal damage.
Hemodynamic deterioration during follow-up may also increase the risk of subsequent selective cortical neuronal damage, particularly in patients who do not have misery perfusion at baseline. 4 In this study, the progression of cortical neuronal damage was also associated with an increased OEF during follow-up, which is indicative of hemodynamic deterioration. The relationship between an increased BZR index and an increased OEF during follow-up became apparent after adjusting for the effects of decreased CBF at baseline. Changes in the OEF during follow-up were negatively correlated with OEF values at baseline, which indicated that patients without misery perfusion at baseline experienced larger increases in the OEF during followup. In patients without misery perfusion at baseline, large reductions in perfusion associated with an increased OEF led to subsequent neuronal damage ( Figure I in the onlineonly Data Supplement). Alternatively, among patients with misery perfusion at baseline, small reductions in cerebral perfusion and small increases in the OEF were sufficient to produce neuronal damage. The development of this damage may have, in turn, decreased the OEF by decreasing the metabolic demand of the tissue (Figure 1 ). Furthermore, OEF may decline after neuronal damage because of slow improvement of collateral blood flow. 26 These hypotheses explain why adjusting for decreased CBF at baseline uncovered the association between increased BZR index and an increased OEF during follow-up. Indeed, the contribution of hemodynamic deterioration to selective neuronal damage during follow-up differed between patients with and without misery perfusion at baseline.
The findings presented here have important implications for the clinical prevention of cortical neuronal damage by atherosclerotic ICA or MCA disease. First, it should be recognized that the progression of selective cortical neuronal damage occurs in association with chronic hemodynamic impairment and in the absence of an overt stroke episode. Thus, evaluation of hemodynamic status at baseline or follow-up is essential for the prevention of subsequent neuronal damage. Vascular reconstruction surgery can improve hemodynamic impairment and therefore may be indicated for patients vulnerable to selective neuronal damage.
The precise reason for the hemodynamic deterioration can be unclear in individual patients; however, the aggravation of vascular risk factors and the progression of athero-or arteriosclerosis may lead to chronic decreases in collateral flow. 4 In this study, the progression of atherosclerosis on MR angiography was associated with an increased BZR index. An increased OEF during follow-up was associated with the presence of hypercholesterolemia and a lack of statin use during follow-up. Appropriate control of vascular risk factors and statin use may therefore have beneficial effects against hemodynamic deterioration and lead to neuronal protection. Indeed, statin use may reduce the occurrence of selective neuronal damage and infarction because of large artery atherosclerosis. 7, 27 Several studies have shown that statins have beneficial effects on cerebral circulation and brain parenchyma during ischemic stroke and reperfusion. 28 The impact of progressive cortical neuronal damage on clinical outcomes is unclear in this study. Some patients developed new cortical symptoms, which were associated with regional cortical neuronal damage (Figure 1 ; Figure I in the online-only Data Supplement). However, we could not systematically investigate cognitive differences among these patients. Previous cross-sectional studies have demonstrated selective cortical neuronal damage manifested as a decrease in BZRs, which was associated with subtle cognitive impairment. 10, 15 However, a causal relationship between selective neuronal damage and cognitive impairment should be confirmed using follow-up studies. However, standard clinical stroke scales may not be sensitive to subtle cognitive impairments. Furthermore, systematic neuropsychological tests may be needed to detect variable cortical dysfunction caused by regional differences of progressive neuronal damage.
To address these issues, Chida et al 14, 29 used a neuropsychological battery consisting of the Wechsler Adult Intelligence Scale Revised, the Wechsler Memory Scale, and Rey-Osterreith Complex Figure test, before and after carotid endarterectomy. Cerebral hyperperfusion or ischemia after carotid endarterectomy was found to result in a decrease in BZRs that correlated with postoperative cognitive impairment in the absence of new lesions on MRI. Alternatively, improvement of the hemodynamic compromise after carotid endarterectomy was associated with a postoperative increase in BZRs, which was correlated with improved cognitive performance. Therefore, progressive cortical neuronal damage may contribute to the development of subtle poststroke cognitive impairment dependent on the extent on the damage.
The BZR index increased dramatically between baseline and follow-up, whereas changes in hemodynamic and metabolic parameters were less clear. This was especially true in symptomatic patients (Table 4 ). In patients with subcortical stroke at baseline, functional recovery with increased CMRO 2 may have occurred during follow-up. This process may be independent of decreased BZRs during follow-up. Furthermore, hemodynamic impairment may improve after neuronal damage because of the slow improvement of collateral blood flow. Therefore, the change in the hemodynamic or metabolic parameters may be more complex than that for the BZR index, which may affect associations between it and hemodynamic or metabolic parameters. 
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Our previous cross-sectional study did not support a relationship between the extent of subcortical ischemic lesioning and the BZR index, which failed to support the hypothesis that deafferentation because of subcortical infarct caused the decrease in BZR. 7 In this study, progression of subcortical ischemic changes was not correlated with an increased BZR index. This suggests that the effect of subcortical ischemic lesions on cortical neuronal damage may not be large.
Limitations
This study had some limitations. Different sampling methods were used for the BZR and hemodynamic parameters. FMZ BP parametric images were analyzed using a 3D stereotactic surface projection technique, which was based on a pixel-topixel analysis. The BZR index was defined as (% pixels with Z score >2) × (average Z score for those pixels). Thus, this index can reflect both the extent and the severity of decreased BZR. Small foci of BZR decreases can be detected sensitively and are indicated by an increase in the BZR index. The method for 15 O gas PET-scanning analysis used a classical ROI analysis. Calculation of the mean hemispheric value using ROIs placed compactly on multiple image slices could help to diminish error in the definition of an ROI. However, regional changes of the PET measures may be overlooked using these methods. These differences may contribute to the discrepancy between increased BZR and changes in hemodynamic and metabolic parameters. Our study was unable to correct for partial volume effects using MRI because imaging was only performed for clinical purposes. A decrease in cortical FMZ binding could at least partly reflect an increase in cortical atrophy because of ischemic tissue damage (ie, neuronal loss and partial volume effects) as well as decreases in tissue BZR expression. The normal control database was based on scans from only 10 healthy control subjects who were significantly younger than our patients. Additionally, follow-up examinations demonstrating no significant change in Z index during follow-up (mean: 41±3 months) were performed on only 7 of these 10 control subjects.
Conclusions
In patients with atherosclerotic ICA or MCA disease, the progression of selective cortical neuronal damage occurs in the absence of an overt stroke episode and in association with both decreased CBF at baseline and an increased OEF during follow-up. Decreased CBF at baseline may reflect misery perfusion with cortical neuronal damage, whereas an increased OEF during follow-up may reflect hemodynamic deterioration. Thus, to prevent the progression of selective cortical neuronal damage, vascular reconstruction surgery to improve hemodynamic impairment and an appropriate control of vascular risk factors (eg, the use of statin) may be useful.
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